@eclinicalmed.bsky.socialSafety and tolerability of elinzanetant: pooled analysis from four RCTs
The overall safety profile of #elinzanetant appeared favorable in 1113 women with #vasomotor symptoms (VMS) associated with #menopause based on this exploratory pooled safety analysis
@apspublications.bsky.social